Dealing with the seismic effects of the COVID-19 pandemic, the biopharma industry continues to break new ground during a transformative era of product innovation.
Part I: Leaders in healthcare marketing and communications reflect on the push to attract and retain industry talent.
Part II: Leaders in healthcare marketing and communications discuss the looming concerns regarding the healthcare ecosystem.
Part III: Leaders in healthcare marketing and communications explain where technology will have the most impact on the industry.
Part IV: Leaders in healthcare marketing and communications talk about what their organizations are doing to ensure that diversity, equity, and inclusion continues to be a prominent part of the conversation, with actionable impact and results.
Part V: Leaders in healthcare marketing and communications share their thoughts on what excites them about the year ahead.
The top pharmaceutical companies and brands in this year’s Outcomes Creativity Index elevated their messaging by breaking down barriers, debunking myths and giving patients a stronger voice.
For Med Ad News’ 36th annual special report, the publication’s editors rank the world’s top 50 companies that generate revenue from prescription medicines and healthcare products.
The biopharma industry’s response to the global pandemic has propelled some COVID-19 vaccines into the leading ranks of the world’s best-selling products, with Pfizer/BioNTech’s Comirnaty surpassing AbbVie’s Humira for the No. 1 spot.
The values of leading pharmaceutical brands have skyrocketed during the COVID-19 pandemic; Johnson & Johnson retains the top position.